Association of human immunodeficiency virus Nef protein with actin is myristoylation dependent and influences its subcellular localization

被引:71
作者
Fackler, OT
Kienzle, N
Kremmer, E
Boese, A
Schramm, B
Klimkait, T
Kucherer, C
MuellerLantzsch, N
机构
[1] UNIV SAARLANDES KLINIKEN,INST MED MIKROBIOL & HYG,VIROL LAB,ABT VIROL,D-66421 HOMBURG,GERMANY
[2] GSF MUNICH,INST IMMUNOL,MUNICH,GERMANY
[3] NOVARTIS PHARMA INC,BASEL,SWITZERLAND
[4] ROBERT KOCH INST,D-1000 BERLIN,GERMANY
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 1997年 / 247卷 / 03期
关键词
human immunodeficiency virus; Nef protein; actin; protein interaction; subcellular localization;
D O I
10.1111/j.1432-1033.1997.00843.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human immunodeficiency virus (HIV) Nef functions are thought to be mediated via interactions with cellular proteins. Utilizing zone velocity sedimentation in glycerol gradients we found that recombinant HIV-1 Nef non-covalently associates with actin forming a high-molecular-mass complex of 150-300 kDa. This Nef/actin complex was present in human B and T lymphocytes but not in insect cells and was dependent on the N-terminal myristoylation of Nef, whereas the SH3-binding proline motif of Nef was not involved. Despite being myristoylated, HIV-2 Nef did not associate with actin. This might reflect differences in the subcellular localization of Nef since cell-fractionation experiments revealed that HIV-1 Nef was virtually exclusively localized in the cytoskeletal (detergent-insoluble) fraction whereas HIV-2 Nef heel significantly reduced affinity for the cytoskeleton. Colocalization experiments in HIV-1-infected CD4+ fibroblasts revealed that Nef/actin complexes may also exist in HIV-infected cells. This novel interaction of HIV-1 Nef with actin provides insight into the association of Nef with cellular structures and reveals general differences in the interactions of the Nef proteins from HIV-1 and HIV-2.
引用
收藏
页码:843 / 851
页数:9
相关论文
共 64 条
[1]   CELLULAR PROTEINS BOUND TO IMMUNODEFICIENCY VIRUSES - IMPLICATIONS FOR PATHOGENESIS AND VACCINES [J].
ARTHUR, LO ;
BESS, JW ;
SOWDER, RC ;
BENVENISTE, RE ;
MANN, DL ;
CHERMANN, JC ;
HENDERSON, LE .
SCIENCE, 1992, 258 (5090) :1935-1938
[2]   REGULATION OF HUMAN-IMMUNODEFICIENCY-VIRUS NEF PROTEIN BY PHOSPHORYLATION [J].
BANDRES, JC ;
LURIA, S ;
RATNER, L .
VIROLOGY, 1994, 201 (01) :157-161
[3]  
BAUERLE PA, 1988, SCIENCE, V242, P540
[4]   The N-terminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase [J].
Baur, AS ;
Sass, G ;
Laffert, B ;
Willbold, D ;
ChengMayer, C ;
Peterlin, BM .
IMMUNITY, 1997, 6 (03) :283-291
[5]   HIV-1 NEF LEADS TO INHIBITION OR ACTIVATION OF T-CELLS DEPENDING ON ITS INTRACELLULAR-LOCALIZATION [J].
BAUR, AS ;
SAWAI, ET ;
DAZIN, P ;
FANTL, WJ ;
CHENGMAYER, C ;
PETERLIN, BM .
IMMUNITY, 1994, 1 (05) :373-384
[6]  
BENICHOU S, 1994, J BIOL CHEM, V269, P30073
[7]   IN-VITRO BINDING AND PHOSPHORYLATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEF PROTEIN BY SERINE THREONINE PROTEIN-KINASE [J].
BODEUS, M ;
MARIECARDINE, A ;
BOUGERET, C ;
RAMOSMORALES, F ;
BENAROUS, R .
JOURNAL OF GENERAL VIROLOGY, 1995, 76 :1337-1344
[8]   DIFFERENTIAL-EFFECTS OF NEF ON HIV REPLICATION - IMPLICATIONS FOR VIRAL PATHOGENESIS IN THE HOST [J].
CHENGMAYER, C ;
IANNELLO, P ;
SHAW, K ;
LUCIW, PA ;
LEVY, JA .
SCIENCE, 1989, 246 (4937) :1629-1632
[9]   OPTIMAL INFECTIVITY IN-VITRO OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REQUIRES AN INTACT NEF GENE [J].
CHOWERS, MY ;
SPINA, CA ;
KWOH, TJ ;
FITCH, NJS ;
RICHMAN, DD ;
GUATELLI, JC .
JOURNAL OF VIROLOGY, 1994, 68 (05) :2906-2914
[10]   MOLECULAR-CLONING AND POLYMORPHISM OF THE HUMAN IMMUNE-DEFICIENCY VIRUS TYPE-2 [J].
CLAVEL, F ;
GUYADER, M ;
GUETARD, D ;
SALLE, M ;
MONTAGNIER, L ;
ALIZON, M .
NATURE, 1986, 324 (6098) :691-695